Veterans affairs cooperative studies program study 553: Chemotherapy after prostatectomy, a phase III randomized study of prostatectomy versus prostatectomy with adjuvant docetaxel for patients with high-risk, localized prostate cancer

被引：13
|
作者：
Montgomery, Bruce [1 ]
Lavori, Philip
Garzotto, Mark
Lee, Kelvin
Brophy, Mary
Thaneemit-Chen, Surai
Kelly, William
Basler, Joseph
Ringer, Robert
Yu, Wei
Whittemore, Alice
Lin, Daniel W.
机构：
[1] Vet Affairs Puget Sound Hlth Care Syst, Div Med Oncol, Seattle, WA 98109 USA
来源：
UROLOGY | 2008年 / 72卷 / 03期
关键词：
D O I：
10.1016/j.urology.2008.02.050
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：474 / 480
页数：7
相关论文
共 50 条
  • [41] Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005
    Chang, Kun
    Qin, Xiao-Jian
    Zhang, Hai-Liang
    Dai, Bo
    Zhu, Yao
    Shi, Guo-Hai
    Shen, Yi-Jun
    Zhu, Yi-Ying
    Ye, Ding-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2016, 18 (03) : 452 - 455
  • [42] Adjuvant androgen deprivation and chemotherapy for patients with high risk prostate cancer progression after radical prostatectomy: Preliminary study on toxicity and side effects
    De La Taille, A.
    Allory, Y.
    Vacherot, F.
    Terry, S.
    Maille, P.
    Campos, J. L.
    Salomon, L.
    Vordos, D.
    Larre, S.
    Hoznek, A.
    Rene, Y.
    Abbou, C.
    Paule, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 28 - 28
  • [43] Early postoperative Radiotherapy after radical Prostatectomy in High-risk Prostate Cancer Patients
    Ehmann, M.
    Wenz, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 (05) : 431 - 432
  • [44] "Radical Prostatectomy: Adjuvant versus Salvage Radiation" and "High-risk Prostate Cancer: Adjuvant versus early Salvage Radiation" Comment
    Mandel, Philipp
    Hoeh, Benedikt
    AKTUELLE UROLOGIE, 2022, 53 (01) : 13 - 15
  • [45] Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
    Joniau, Steven
    Spahn, Martin
    EUROPEAN UROLOGY, 2011, 60 (05) : 1121 - 1122
  • [46] Re: Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study
    Rozet, Francois
    Mongiat-Artus, Pierre
    EUROPEAN UROLOGY, 2011, 60 (03) : 598 - 599
  • [47] Neoadjuvant docetaxel and estramustine followed by radical prostatectomy or radiation therapy for patients with high-risk prostate cancer
    Stefaniak, H
    Wallen, E
    Baggstrom, M
    Godley, P
    Rosenman, J
    Goyal, L
    Whang, Y
    Pruthi, RS
    JOURNAL OF UROLOGY, 2005, 173 (04): : 190 - 190
  • [48] ADJUVANT MAXIMUM ANDROGEN BLOCKAGE COMPARED WITH BICALUTAMIDE 150MG IN PATIENTS WITH LOCALIZED HIGH-RISK PROSTATE CANCER AFTER RADICAL PROSTATECTOMY
    Chang, Kun
    Qin, Xiao-jian
    Ye, Ding-wei
    JOURNAL OF UROLOGY, 2016, 195 (04): : E996 - E997
  • [49] Adjuvant enzalutamide (Enza) for men with high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).
    Ornstein, Moshe Chaim
    Stephenson, Andrew J.
    Elson, Paul
    Tyler, Allison Janine
    Profusek, Pam
    Grivas, Petros
    Rini, Brian I.
    Klein, Eric A.
    Garcia, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] A pilot multicenter phase II study of adjuvant docetaxel (D) for high risk prostate cancer (PC) patients (pts) after radical prostatectomy (RP): Preliminary data.
    Rosenbaum, E
    Kibel, A
    Roth, B
    Wilding, G
    Dreicer, R
    Chatta, G
    Petrylak, D
    Dipaula, RS
    Beer, TM
    Eisenberger, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 394S - 394S
12345